PART I . Overview We are a clinical-stage pharmaceutical company developing treatments for cannabis-induced toxicity, such as acute cannabis-induced toxicity in children, acute cannabinoid intoxication (ACI) and the broader landscape of acute cannabis-induced conditions. Our lead product candidate, selonabant (formerly ANEB-001), is intended to rapidly reverse the negative effects of cannabis-induced toxicity and reduce time to recovery. Pediatric patients exposed to cannabis are at risk of seri...
Q2 FY2026 — expected 2026-09-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-09-29 | 2025-06-30 | 0001493152-25-016015 | EDGAR | 81K words |
| 2024-09-25 | 2024-06-30 | 0001493152-24-038127 | EDGAR | — |
| 2023-09-22 | 2023-06-30 | 0001493152-23-033452 | EDGAR | — |
| 2022-09-09 | 2022-06-30 | 0001493152-22-025448 | EDGAR | — |
| 2021-09-22 | 2021-06-30 | 0001493152-21-023373 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-12 | 2025-12-31 | 0001493152-26-006446 | EDGAR | 21K words |
| 2025-11-13 | 2025-09-30 | 0001493152-25-022350 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001641172-25-009975 | EDGAR | — |
| 2025-02-14 | 2024-12-31 | 0001493152-25-006893 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001493152-24-045151 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019922 | EDGAR | — |
| 2024-02-13 | 2023-12-31 | 0001493152-24-006103 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-041171 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001493152-23-016382 | EDGAR | — |
| 2023-02-10 | 2022-12-31 | 0001493152-23-004203 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031239 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0001493152-22-012848 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-12 | 0001493152-26-006428 | EDGAR | 1K words |
| 2026-02-06 | 0001493152-26-005463 | EDGAR | — |
| 2026-01-29 | 0001493152-26-004154 | EDGAR | — |
| 2026-01-27 | 0001493152-26-003718 | EDGAR | — |
| 2025-12-22 | 0001493152-25-028676 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022310 | EDGAR | — |
| 2025-09-29 | 0001493152-25-016001 | EDGAR | — |
| 2025-09-12 | 0001493152-25-013133 | EDGAR | — |
| 2025-07-23 | 0001493152-25-011342 | EDGAR | — |
| 2025-05-13 | 0001641172-25-009952 | EDGAR | — |
82 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001815974 |
| Ticker | ANEB |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report